Benchmark Apts Drug Elimination Boston, MA - 02121

Benchmark Apts Drug Elimination is categorized under Data Processing Schools in Boston, MA and active since 2004.

Benchmark Apts Drug Elimination was established in 2004, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Data Processing Schools business, which does work in the B2C market, and is classified as a Data Processing Schools, under code number 611420 by the NAICS.

If you are seeking more information, feel free to contact Yvonne Bermudez at the company’s single location by writing to 164 Seaver St, Boston, Massachusetts MA 02121 or by phoning (617) 427-3360. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Benchmark Apts Drug Elimination
Contact Person: Yvonne Bermudez
Address: 164 Seaver St, Boston, Massachusetts 02121
Phone Number: (617) 427-3360
Annual Revenue (USD): $100.000 to $499.999
Founded: 2004
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Data Processing Schools
SIC Code: 8243
NAICS Code: 611420
Share This Business:

Benchmark Apts Drug Elimination was started in 2004 to provide professional Data Processing Schools under the SIC code 8243 and NAICS code 611420. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.

Feel free to contact Yvonne Bermudez for inquiries that concern Benchmark Apts Drug Elimination by calling the company number (617) 427-3360, as your correspondence is most welcome. Additionally, the physical location of the single location of Benchmark Apts Drug Elimination can be found at the coordinates 42.308441,-71.089842 as well as the street address 164 Seaver St in Boston, Massachusetts 02121.

For its online presence, you may visit Benchmark Apts Drug Elimination’s website at and engage with its social media outlets through on Twitter and on Facebook.